These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Vasculitis and vasculopathy]. Marković A. Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816 [Abstract] [Full Text] [Related]
7. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders. Criado PR, Alavi A, Halpern I, Sotto MN, Kirsner RS. Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683 [Abstract] [Full Text] [Related]
8. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease. Reagin H, Marks E, Weis S, Susa J. Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274 [Abstract] [Full Text] [Related]
9. Livedoid vasculopathy as a coagulation disorder. Criado PR, Rivitti EA, Sotto MN, de Carvalho JF. Autoimmun Rev; 2011 Apr; 10(6):353-60. PubMed ID: 21184847 [Abstract] [Full Text] [Related]
10. Livedoid vasculopathy: an intringuing cutaneous disease. Criado PR, Rivitti EA, Sotto MN, Valente NY, Aoki V, Carvalho JF, Vasconcellos C. An Bras Dermatol; 2011 Apr; 86(5):961-77. PubMed ID: 22147037 [Abstract] [Full Text] [Related]
11. Livedoid vasculopathy - A diagnostic and therapeutic challenge. Burg MR, Mitschang C, Goerge T, Schneider SW. Front Med (Lausanne); 2022 Apr; 9():1012178. PubMed ID: 36262273 [Abstract] [Full Text] [Related]
12. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin. Osada S, Kimura Y, Kawana S. J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830 [Abstract] [Full Text] [Related]
16. Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases. Tubone MQ, Escobar GF, Peruzzo J, Schestatsky P, Maldonado G. An Bras Dermatol; 2013 Dec; 88(6 Suppl 1):227-9. PubMed ID: 24346927 [Abstract] [Full Text] [Related]
17. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin]. Becker A, Stoffels-Weindorf M, Schimming T, Dissemond J. Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447 [Abstract] [Full Text] [Related]
18. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban. Franco Marques G, Criado PR, Alves Batista Morita TC, Cajas García MS. Int J Dermatol; 2018 Jun; 57(6):732-741. PubMed ID: 29663354 [Abstract] [Full Text] [Related]
19. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy. Furukawa F, Mizawa M, Makino T, Shimizu T. BMJ Case Rep; 2017 Jul 24; 2017():. PubMed ID: 28739563 [Abstract] [Full Text] [Related]
20. Negative Results, Positive Outcome: A Case of Primary Livedoid Vasculopathy With an Elusive Laboratory Workup. Al-Obaidi AD, Sabeeh SK, Mohammed MJ, Othman A, Algburi YA, Hashim HT, Alhatemi AQM, Al Hilali Z, Al-Attabi BRT, Al-Awad A. J Investig Med High Impact Case Rep; 2024 Jul 24; 12():23247096241266090. PubMed ID: 39068597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]